Works about IMMUNE checkpoint inhibitors

Results: 5000

Abscopal Effects and Immunomodulation in Skin Cancer Therapy.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 555, doi. 10.1007/s40257-025-00943-x

By:

Nahm, William J.;
Sakunchotpanit, Goranit;
Nambudiri, Vinod E.

Publication type:

Article

The use of peripheral blood biomarkers for predicting the risk of immune-related adverse events in immune checkpoint inhibitor therapy.

Published in:

Annals of Clinical Biochemistry, 2025, v. 62, n. 4, p. 236, doi. 10.1177/00045632241312629

By:

Duvall, Louise E

Publication type:

Article

FDA approves durvalumab for perioperative immunotherapy for patients with muscle‐invasive bladder cancer: In a prespecified analysis, the trial demonstrated a statistically significant improvement in event‐free survival and overall survival.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35912

By:

Nierengarten, Mary Beth

Publication type:

Article

Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604826

By:

Pacholczak-Madej, Renata;
Lisik-Habib, Maja;
Mądry, Radosław;
Szarszewska, Monika;
Borysiewicz, Zuzanna;
Gabalewicz, Katarzyna;
Iwańska, Ewa;
Szatkowski, Wiktor;
Puskulluoglu, Mirosława;
Jakubowicz, Jerzy;
Blecharz, Paweł

Publication type:

Article

Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1598436

By:

Wu, Dongjuan;
Fan, Yaohua;
Zhang, Mingsheng;
Wang, Xiaoguang;
He, Xuesong;
Guo, Xinwei;
Liu, Yangchen;
Cao, Chenxi;
Deng, Zhaoqun

Publication type:

Article

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB−TACE combined with lenvatinib and camrelizumab.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1549675

By:

Xu, Baiguo;
Cui, Yufeng;
Wang, Ning;
Gao, Zhongsong;
Ye, Qing;
Xiang, Huiling

Publication type:

Article

Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1533874

By:

El-Kafrawy, Sherif A.;
Elkafrawy, Mostafa S.;
Azhar, Esam I.;
Saeed, Anwaar;
Tabll, Ashraf A.

Publication type:

Article

A giant peritoneal mesothelioma extending to the pelvic floor: A case report and review of the literature.

Published in:

2025

By:

Thomas, Mathew;
Nandakumar, Harikrishnan;
Sampat, Parth;
Graziano, Stephen

Publication type:

Case Study

Extended field chemoradiation in M1a bladder carcinoma: A case report.

Published in:

Journal of Cancer Research & Therapeutics, 2025, v. 21, n. 3, p. 725, doi. 10.4103/jcrt.jcrt_2393_23

By:

Periasamy, Kannan;
Goyal, Shikha;
Kumar, Santosh;
Chandran, Vigneshwaran;
Kumar, Rajender

Publication type:

Article

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis.

Published in:

eLife, 2025, p. 1, doi. 10.7554/eLife.103559

By:

Yiran Zhang;
Hanyang Guan;
Shijin Liu;
Haoquan Li;
Zili Bian;
Jiashuai He;
Zhan Zhao;
Shenghui Qiu;
Tianmu Mo;
Xiangwei Zhang;
Zuyang Chen;
Hui Ding;
Xiaoxu Zhao;
Liang Wang;
Yunlong Pan;
Jinghua Pan

Publication type:

Article

TRPV1 inhibition sensitizes tumors to PD-1 blockade by reversing resistance to CTL-mediated killing.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-07120-4

By:

Son, Min Kyu;
Lee, Hyo-Jung;
Cho, Eunho;
Oh, Se Jin;
Kim, Tae Woo

Publication type:

Article

Abnormal gut microbiota may cause PD-1 inhibitor-related cardiotoxicity via suppressing regulatory T cells.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-05635-4

By:

Cao, Huili;
Dai, Huwei;
Li, Songshan;
Afzal, Zeeshan;
Wang, Xinyan;
Wen, Zeyu;
Xiao, Kaiyong;
Zhao, Yajing;
Li, Jin;
Yang, Bin

Publication type:

Article

Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients.

Published in:

European Radiology, 2025, v. 35, n. 8, p. 4417, doi. 10.1007/s00330-025-11351-4

By:

Wiley, Natalie;
Zecevic, Mladen;
Ho, Vivian;
Stolzberg, Matthew J.;
Cox, Danielle;
Soloff, Erik V.;
Hall, Evan;
Wang, Carolyn L.

Publication type:

Article

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

Published in:

Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02383-x

By:

Cui, Yanan;
Qiu, Tianyu;
Wang, Jiale;
Liu, Xinyu;
Luo, Libo;
Yin, Jizhong;
Zhi, Xinxin;
Wang, Wanying;
Feng, Gaohua;
Wu, Chunyan;
Zhao, Zhikai;
Zhang, Hua;
Li, Fei;
Wu, Fengying;
Ren, Shengxiang

Publication type:

Article

The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.

Published in:

Journal of Immunology Research, 2025, v. 2025, p. 1, doi. 10.1155/jimr/8890939

By:

Daghaighei, Mona;
Dodge, Samaneh;
Bolandi, Soheil;
Youssef, Boutros;
Attarde, Niket;
Maddahi, Moein;
Mostofi, Maryam;
Morovatshoar, Reza;
Mostafavi, Mehrnaz;
Majid, Dejbakht;
Joulani, Mohammadamin;
Tamimi, Pegah;
Sharafi, Malihe;
Behfar, Qumars;
Boushehri, Yasaman Ghodsi;
Azani, Alireza;
Goyal, Manish

Publication type:

Article

Single‑cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03068-z

By:

Li, Boyang;
Lin, Ruonan;
Hua, Yibo;
Ma, Binlin;
Chen, Yi

Publication type:

Article

Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers.

Published in:

PLoS ONE, 2025, v. 20, n. 7, p. 1, doi. 10.1371/journal.pone.0326057

By:

Wang, Jingliang;
Wang, Weihao;
Liu, Bin;
Zhao, Rui;
Zhao, Jing;
Jiang, Fengxian;
Xu, Wei;
Zhang, Zhizhao;
Ran, Pancen;
Shu, Yang;
Wang, Yahui;
Pan, Liying;
Liu, Lei;
Luan, Fang;
Fu, Guobin

Publication type:

Article

PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1602752

By:

Wang, Weihao;
Zhao, Rui;
Wang, Yahui;
Pan, Liying;
Luan, Fang;
Fu, Guobin

Publication type:

Article

Comprehensive analysis of RFC4 as a potential biomarker for regulating the immune microenvironment and predicting immune therapy response in lung adenocarcinoma.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1578243

By:

Zheng, Jianqing;
Lin, Na;
Huang, Bifen;
Wu, Min;
Xiao, Lihua;
Zeng, Bingwei

Publication type:

Article

Optimization of systemic treatment in patients with bladder, ureter, and renal pelvis cancer -- expert opinion of the Polish Society of Clinical Oncology.

Published in:

Oncology in Clinical Practice (2450-1654), 2025, v. 21, n. 3, p. 177, doi. 10.5603/ocp.102532

By:

Wysocki, Piotr J.;
Krzakowski, Maciej;
Kwinta, Łukasz;
Kucharz, Jakub;
Skoneczna, Iwona;
Wiechno, Paweł

Publication type:

Article

Cardiotoxicity in cancer immunotherapy: a systematic review and global meta-analysis.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06768-w

By:

Zhou, Fanlin;
Liu, Guangyue;
Zhang, Shunhong;
Luo, Chenchen;
Hu, Saidi;
Wan, Siran;
Xiong, Weixi;
Zhao, Linyong

Publication type:

Article

MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma.

Published in:

BMC Medical Imaging, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12880-025-01751-9

By:

Zhang, Rui;
Peng, Wei;
Wang, Yao;
Jiang, Yunping;
Wang, Junli;
Zhang, Siying;
Li, Zhi;
Shi, Yushu;
Chen, Feng;
Feng, Zhan;
Xiao, Wenbo

Publication type:

Article

Computed tomography-based radiomics predicts prognostic and treatment-related levels of immune infiltration in the immune microenvironment of clear cell renal cell carcinoma.

Published in:

BMC Medical Imaging, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12880-025-01749-3

By:

Song, Shiyan;
Ge, Wenfei;
Qi, Xiaochen;
Che, Xiangyu;
Wang, Qifei;
Wu, Guangzhen

Publication type:

Article

Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60827-w

By:

Zenga, Joseph;
Awan, Musaddiq J.;
Frei, Anne;
Foeckler, Jamie;
Kuehn, Rachel;
Kasprzak, Julia;
Massey, Becky;
Bruening, Jennifer;
Akakpo, Kenneth;
Shukla, Monica;
Wong, Stuart J.;
Mathison, Angela J.;
Wendt Andrae, Jaime;
Hunt, Bryan;
Puzyrenko, Andrii;
Jin, Victor X.;
Memon, Abdullah A.;
Villarreal Espinosa, Oscar;
Chen, Fanghong;
Shaheduzzaman, Md

Publication type:

Article

Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60657-w

By:

Damei, Isabelle;
Caidi, Aziza;
Auclin, Edouard;
Adam, Julien;
Mella, Sébastien;
Hasan, Milena;
Tartour, Eric;
Robert, Caroline;
Corgnac, Stéphanie;
Mami-Chouaib, Fathia

Publication type:

Article

Nivolumab Induced Palmoplantar Keratoderma.

Published in:

Indian Dermatology Online Journal, 2025, v. 16, n. 4, p. 628, doi. 10.4103/idoj.idoj_422_24

By:

Sushma, Singamsetty;
Haritha, Kollipara;
Rao, Gandikota Raghurama;
Karri, Sudhir Babu

Publication type:

Article

Cardiovascular adverse effects of immunotherapy in cancer: insights and implications.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1601808

By:

Du, Haiping;
Wang, Jie;
Wang, Zhen

Publication type:

Article

Editorial: Combination immunotherapy and immune response assessment of brain tumours.

Published in:

2025

By:

Jiang, Haihui

Publication type:

Editorial

Case Report: Hepatic sarcoidosis-like reaction from neoadjuvant pembrolizumab in early-stage triple-negative breast cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1589191

By:

Tan, Yujing;
Wang, Yu;
Liu, Xiaoyan;
Ma, Qin;
Zeng, Cheng;
Zhu, Aihua;
Sun, Xiaoying;
Ma, Fei;
Wang, Jiani

Publication type:

Article

Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1583363

By:

Lu, Hua;
Teng, Zhaojun;
Wang, Jiajia;
Zhang, Wenchao

Publication type:

Article

Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03442-3

By:

Ifejeokwu, Onwodi V.;
Do, An H.;
El Khatib, Sanad M.;
Ho, Nhu N.;
Zavala, Angel;
Othy, Shivashankar;
Acharya, Munjal M.

Publication type:

Article

Elucidating the role of N-myristoylation in the excessive membrane localization of PD-L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03438-z

By:

Zhao, Haoming;
Zhang, Zhen;
Zhang, Chaojun;
Ma, Hexin;
Wan, Qingqing;
Zhao, Xinran;
Wang, Xu;
Yan, Ming;
Guo, Haiyan;
Zhang, Jianjun;
Chen, Wantao

Publication type:

Article

Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00987-6

By:

Hallaert, Patrick;
Roman, John W.;
Baker, Mairead;
Hill, Natasha T.;
Marte, Jennifer L.;
Gulley, James L.;
Logemann, Nicholas;
Hudgens, Courtney W.;
Reuben, Alexandre;
Brownell, Isaac

Publication type:

Article

A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRI.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01007-3

By:

Alvarez-Jimenez, Charlems;
Antunes, Jacob T.;
DeSilvio, Thomas;
Wei, Zhouping;
Ismail, Marwa;
Willis, Joseph E.;
Steinhagen, Emily;
Purysko, Andrei;
Liska, David;
Krishnamurthi, Smitha;
Crittenden, Marka;
Gough, Michael;
Young, Kristina;
Madabhushi, Anant;
Romero, Eduardo;
Tiwari, Pallavi;
Viswanath, Satish E.

Publication type:

Article

CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms.

Published in:

Cancer Genomics & Proteomics (1109-6535), 2025, v. 22, n. 4, p. 557, doi. 10.21873/cgp.20521

By:

WAZIR, UMAR;
LI, AMBER X.;
CAROLYN CAI WANG;
HENSON HAN GAO;
MARTIN, TRACEY A.;
JIANG, WEN G.;
MOKBEL, KEFAH

Publication type:

Article

Characteristics of the gut microbiota in patients with advanced non-small cell lung cancer who responded to immune checkpoint inhibitors.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-08049-4

By:

Komatsu, Hideyuki;
Sugimoto, Takuya;
Ogata, Yuzuru;
Miura, Takahito;
Aida, Masanori;
Nishiyama, Hiroyuki;
Kawai, Mitsuhisa;
Yano, Yukihiro;
Mori, Masahide;
Shishido, Yoshiyuki

Publication type:

Article

Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 7, p. 839, doi. 10.1080/14740338.2024.2385489

By:

Xi, Xin;
Yan, Xida;
Chen, Ying;
Li, Wenjun;
Dong, Jie;
Ou, Xuan;
Tan, Haowen

Publication type:

Article

Recent Advances in Management of Vitiligo.

Published in:

Indian Journal of Dermatology, 2025, v. 70, n. 4, p. 201, doi. 10.4103/ijd.ijd_158_25

By:

Das, Kinnor;
Sarkar, Rashmi;
Sinha, Surabhi

Publication type:

Article

Longitudinally extensive transverse myelitis after pembrolizumab and lenvatinib therapy for a rare subtype of renal cell carcinoma: A case report.

Published in:

Oncology Letters, 2025, v. 30, n. 2, p. N.PAG, doi. 10.3892/ol.2025.15132

By:

Piętak, Mateusz;
Kruczyk, Barbara;
Domański, Piotr;
Jarosińska, Jadwiga;
Hołdakowska, Anna;
Demkow, Tomasz;
Kucharz, Jakub

Publication type:

Article

Structure–activity relationship of <sup>18</sup>F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance.

Published in:

EJNMMI Radiopharmacy & Chemistry, 2025, v. 10, n. 1, p. 1, doi. 10.1186/s41181-025-00359-2

By:

Krutzek, Fabian;
Donat, Cornelius K.;
Stadlbauer, Sven

Publication type:

Article

Arsenic Trioxide Enhances the Efficacy of PD‐1 Inhibitors in Hepatocellular Carcinoma by Inducing Immunogenic Cell Death via the ROS/ERS Pathway.

Published in:

Immunity, Inflammation & Disease, 2025, v. 13, n. 6, p. 1, doi. 10.1002/iid3.70214

By:

Wang, Xionghui;
Cheng, Simo;
Xu, Yannan;
Zheng, Tianxiao;
Ling, Changquan;
Du, Juan

Publication type:

Article

Editorial: New Target for Skin Cancer.

Published in:

2025

By:

Nakamura, Motoki;
Ogata, Dai

Publication type:

Editorial

Letter on 'Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma'.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 62, n. 2, p. 236, doi. 10.1111/apt.70210

By:

Kim, Dong Hyun;
Lee, Hye Won

Publication type:

Article

Predicting the occurrence of liver injury induced by immune checkpoint inhibitors in hepatocellular carcinoma patients: a retrospective analysis.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14540-y

By:

Li, Xiaoyan;
Sun, Hang;
Wang, Jialiang;
Chen, Lubiao

Publication type:

Article

Pre-treatment peripheral blood TCR repertoire as a predictor of response in patients with NSCLC treated with immunochemotherapy.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14523-z

By:

Yang, Yong;
Jiang, Hui-yu;
Li, Yuan;
Wu, Fang;
Chen, Zhao-yang;
Zheng, Guo-ping;
Su, Wen-Zhong;
Wang, Hai-long;
Pang, Min

Publication type:

Article

Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14480-7

By:

Long, Liuhua;
Jiang, Leilei;
Teng, Yue;
Yang, Dan;
Dong, Xin;
Zhao, Yuting;
Deng, Wei;
Yu, Jiayi;
Chang, Xiao;
Shi, Anhui;
Yu, Rong;
Yu, Huiming

Publication type:

Article

Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14458-5

By:

Zhang, Jian;
Wu, Zijie;
Wang, Shuyun;
Sun, Yanxin;
Wu, Jiake;
Wang, Dahai;
Ge, Yihui;
Li, Juan;
Sun, Haifeng;
Cheng, Qinglei;
Gao, Aiqin;
Sun, Yuping

Publication type:

Article

Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14436-x

By:

Huang, Yuxin;
Hu, Yi

Publication type:

Article

Safety and efficacy of atezolizumab/bevacizumab in unresectable hepatocellular carcinoma—a multicentric study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14400-9

By:

Babu, Merin;
Komaranchath, Ashok Sebastian;
Valsan, Arun;
Warrier, Arun R.;
MP, Rakesh;
Jose, Wesley M.;
Haridas, Nikhil K.;
Soman, Sumi;
Nair, Manjima P.;
Sadasivan, Shine;
Menon, Abhinav;
Thabrez, Mohammed;
Pavithran, Keechilat

Publication type:

Article

Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf151

By:

Isawa, Tsuyoshi;
Togashi, Shintaro;
Taguri, Masataka;
Toi, Yukihiro;
Sugawara, Shunichi;
Toyoda, Shigeru

Publication type:

Article